The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sandberg, J. K.
Right arrow Articles by Kärre, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sandberg, J. K.
Right arrow Articles by Kärre, K.
The Journal of Immunology, 1998, 160: 3163-3169.
Copyright © 1998 by The American Association of Immunologists

Superdominance Among Immunodominant H-2Kb-Restricted Epitopes and Reversal by Dendritic Cell-Mediated Antigen Delivery1

Johan K. Sandberg2, Per Grufman, Elisabeth Z. Wolpert, Lars Franksson, Benedict J. Chambers and Klas Kärre

Microbiology and Tumor Biology Center, Karolinska Institute, Stockholm, Sweden

To examine possible interference patterns between immunodominant CTL Ags, we analyzed the response to mixtures of five well-characterized H-2Kb-restricted epitopes, each of which had earlier been described as immunodominant within its antigenic system. Clear patterns of dominance were observed between peptides in the mixture, with the CTL response focusing on the Sendai virus nucleoprotein 324–332 and vesicular stomatitis virus nucleoprotein 52–59 epitopes. The dominance of these epitopes correlated with high CTL availability. Subdominance of the OVA257–264 and the MCF1233 murine leukemia virus envelope 574–581 peptides could not be explained by inferior ability to bind and stabilize MHC class I molecules. Interestingly, immunodominance was broken if the peptide mixture was pulsed on bone marrow-derived dendritic cells, a mode of immunization allowing efficient recognition of a broader set of specificities. Our results show that immunodominance is neither an absolute feature of a given epitope nor does it apply only in relation to other epitopes within the same protein, micro-organism, or cell. Novel "superdominant" hierarchies emerge in the response against multiple "dominant" epitopes. A T cell competition model to explain the data in terms of a balance influenced by CTL frequencies and available APC capacity is discussed.




This article has been cited by other articles:


Home page
Proc R Soc BHome page
H. R. Fryer, A. Scherer, A. Oxenius, R. Phillips, and A. R. McLean
No evidence for competition between cytotoxic T-lymphocyte responses in HIV-1 infection
Proc R Soc B, December 22, 2009; 276(1677): 4389 - 4397.
[Abstract] [Full Text] [PDF]


Home page
J Med MicrobiolHome page
H. Huang, Y.-J. Wang, A. P. White, J.-Z. Meng, G.-R. Liu, S.-L. Liu, and Y.-D. Wang
Salmonella expressing a T-cell epitope from Sendai virus are able to induce anti-infection immunity
J. Med. Microbiol., September 1, 2009; 58(9): 1236 - 1242.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. Riedl, A. Wieland, K. Lamberth, S. Buus, F. Lemonnier, K. Reifenberg, J. Reimann, and R. Schirmbeck
Elimination of Immunodominant Epitopes from Multispecific DNA-Based Vaccines Allows Induction of CD8 T Cells That Have a Striking Antiviral Potential
J. Immunol., July 1, 2009; 183(1): 370 - 380.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. L. Turnbull, M. Wong, S. Wang, X. Wei, N. A. Jones, K. E. Conrod, D. Aldam, J. Turner, P. Pellegrino, B. F. Keele, et al.
Kinetics of Expansion of Epitope-Specific T Cell Responses during Primary HIV-1 Infection
J. Immunol., June 1, 2009; 182(11): 7131 - 7145.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
A. H. Dzutsev, I. M. Belyakov, D. V. Isakov, D. H. Margulies, and J. A. Berzofsky
Avidity of CD8 T cells sharpens immunodominance
Int. Immunol., April 1, 2007; 19(4): 497 - 507.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
I. A. York, M. A. Brehm, S. Zendzian, C. F. Towne, and K. L. Rock
Endoplasmic reticulum aminopeptidase 1 (ERAP1) trims MHC class I-presented peptides in vivo and plays an important role in immunodominance
PNAS, June 13, 2006; 103(24): 9202 - 9207.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. E. Foulds and H. Shen
Clonal Competition Inhibits the Proliferation and Differentiation of Adoptively Transferred TCR Transgenic CD4 T Cells in Response to Infection.
J. Immunol., March 1, 2006; 176(5): 3037 - 3043.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. H. Newberg, K. J. McEvers, D. A. Gorgone, M. A. Lifton, S. H. C. Baumeister, R. S. Veazey, J. E. Schmitz, and N. L. Letvin
Immunodomination in the Evolution of Dominant Epitope-Specific CD8+ T Lymphocyte Responses in Simian Immunodeficiency Virus-Infected Rhesus Monkeys
J. Immunol., January 1, 2006; 176(1): 319 - 328.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Hayakawa, V. Screpanti, H. Yagita, A. Grandien, H.-G. Ljunggren, M. J. Smyth, and B. J. Chambers
NK Cell TRAIL Eliminates Immature Dendritic Cells In Vivo and Limits Dendritic Cell Vaccination Efficacy
J. Immunol., January 1, 2004; 172(1): 123 - 129.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
X. S. Liu, Y. Xu, L. Hardy, V. Khammanivong, W. Zhao, G. J. P. Fernando, G. R. Leggatt, and I. H. Frazer
IL-10 Mediates Suppression of the CD8 T Cell IFN-{gamma} Response to a Novel Viral Epitope in a Primed Host
J. Immunol., November 1, 2003; 171(9): 4765 - 4772.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. Malkevitch, L. J. Patterson, K. Aldrich, E. Richardson, W. G. Alvord, and M. Robert-Guroff
A Replication Competent Adenovirus 5 Host Range Mutant-Simian Immunodeficiency Virus (SIV) Recombinant Priming/Subunit Protein Boosting Vaccine Regimen Induces Broad, Persistent SIV-Specific Cellular Immunity to Dominant and Subdominant Epitopes in Mamu-A*01 Rhesus Macaques
J. Immunol., April 15, 2003; 170(8): 4281 - 4289.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Stober, I. Jomantaite, R. Schirmbeck, and J. Reimann
NKT Cells Provide Help for Dendritic Cell-Dependent Priming of MHC Class I-Restricted CD8+ T Cells In Vivo
J. Immunol., March 1, 2003; 170(5): 2540 - 2548.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
W. Chen, J. R. Bennink, P. A. Morton, and J. W. Yewdell
Mice Deficient in Perforin, CD4+ T Cells, or CD28-Mediated Signaling Maintain the Typical Immunodominance Hierarchies of CD8+ T-Cell Responses to Influenza Virus
J. Virol., September 11, 2002; 76(20): 10332 - 10337.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. Schirmbeck, D. Stober, S. El Kholy, P. Riedl, and J. Reimann
The Immunodominant, Ld-Restricted T Cell Response to Hepatitis B Surface Antigen (HBsAg) Efficiently Suppresses T Cell Priming to Multiple Dd-, Kd-, and Kb-Restricted HBsAg Epitopes
J. Immunol., June 15, 2002; 168(12): 6253 - 6262.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. J. Palmowski, E. M.-L. Choi, I. F. Hermans, S. C. Gilbert, J.-L. Chen, U. Gileadi, M. Salio, A. Van Pel, S. Man, E. Bonin, et al.
Competition Between CTL Narrows the Immune Response Induced by Prime-Boost Vaccination Protocols
J. Immunol., May 1, 2002; 168(9): 4391 - 4398.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Rice, T. Elliott, S. Buchan, and F. K. Stevenson
DNA Fusion Vaccine Designed to Induce Cytotoxic T Cell Responses Against Defined Peptide Motifs: Implications for Cancer Vaccines
J. Immunol., August 1, 2001; 167(3): 1558 - 1565.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Loirat, F. A. Lemonnier, and M.-L. Michel
Multiepitopic HLA-A*0201-Restricted Immune Response Against Hepatitis B Surface Antigen After DNA-Based Immunization
J. Immunol., October 15, 2000; 165(8): 4748 - 4755.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
P. Rawson, I. F. Hermans, S. P. Huck, J. M. Roberts, H. Pircher, and F. Ronchese
Immunotherapy with Dendritic Cells and Tumor Major Histocompatibility Complex Class I-derived Peptides Requires a High Density of Antigen on Tumor Cells
Cancer Res., August 1, 2000; 60(16): 4493 - 4498.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
J. K. Sandberg, L. Franksson, J. Sundback, J. Michaelsson, M. Petersson, A. Achour, R. P. A. Wallin, N. E. Sherman, T. Bergman, H. Jornvall, et al.
T Cell Tolerance Based on Avidity Thresholds Rather Than Complete Deletion Allows Maintenance of Maximal Repertoire Diversity
J. Immunol., July 1, 2000; 165(1): 25 - 33.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Q.-J. Zhang, S. S. Chen, C.-A. Saari, M. G. Massuci, F. Tufaro, and W. A. Jefferies
Evidence of Selective Processing of Immunodominant Epitopes in Virally Infected Cells
J. Immunol., May 1, 2000; 164(9): 4513 - 4521.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Yang, D. Kittlesen, C. L. Slingluff Jr., C. E. Vervaert, H. F. Seigler, and T. L. Darrow
Dendritic Cells Infected with a Vaccinia Vector Carrying the Human gp100 Gene Simultaneously Present Multiple Specificities and Elicit High-Affinity T Cells Reactive to Multiple Epitopes and Restricted by HLA-A2 and -A3
J. Immunol., April 15, 2000; 164(8): 4204 - 4211.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. C. Wilson, W. C. Olson, T. Tuting, C. R. Rinaldo, M. T. Lotze, and W. J. Storkus
HIV-1-Specific CTL Responses Primed In Vitro by Blood-Derived Dendritic Cells and Th1-Biasing Cytokines
J. Immunol., March 1, 1999; 162(5): 3070 - 3078.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. Z. Wolpert, P. Grufman, J. K. Sandberg, A. Tegnesjo, and K. Karre
Immunodominance in the CTL Response Against Minor Histocompatibility Antigens: Interference Between Responding T Cells, Rather than with Presentation of Epitopes
J. Immunol., November 1, 1998; 161(9): 4499 - 4505.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.